金域医学: 广州金域医学检验集团股份有限公司信息披露管理制度

Core Points - The document outlines the information disclosure management system of Guangzhou Kingmed Diagnostics Group Co., Ltd, aiming to standardize disclosure practices and protect investors' rights [1][2][3] - The system applies to various stakeholders, including the board of directors, senior management, and major shareholders, ensuring they adhere to disclosure obligations [2][3] - The company must disclose significant information in a timely, fair, and accurate manner, ensuring all investors have equal access to the same information [3][4][5] Group 1 - The information disclosure is defined as the act of publicly announcing significant information that could impact the company's stock price, in accordance with relevant laws and regulations [1][2] - The company and its related parties are required to ensure the truthfulness, accuracy, and completeness of disclosed information, avoiding misleading statements or omissions [4][5][6] - All significant information must be disclosed simultaneously to all investors, preventing selective disclosure to certain parties [3][4][5] Group 2 - The company must report any undisclosed significant information to the Shanghai Stock Exchange promptly and follow the prescribed disclosure procedures [4][5][6] - The disclosure of information should be based on objective facts and should not exaggerate or mislead [4][5][6] - The company is responsible for ensuring that all disclosures are complete and comply with the required formats [4][5][6] Group 3 - Regular reports, including annual and interim reports, must be disclosed within specified timeframes, with the annual report requiring an audit by a qualified accounting firm [9][10][11] - The company must announce any changes in significant events or circumstances that could affect its securities trading [15][16][17] - The management is responsible for ensuring that all disclosures are made in a timely and accurate manner, with the board of directors overseeing the process [47][48][49]